GEDSF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
5.4B
Intraday BUY SELL Signals
LOVFF
Price
$1.17
Change
-$0.10 (-7.87%)
Updated
Nov 13 closing price
Capitalization
111.76M
Intraday BUY SELL Signals
Interact to see
Advertisement

GEDSF vs LOVFF

Header iconGEDSF vs LOVFF Comparison
Open Charts GEDSF vs LOVFFBanner chart's image
Gedeon Richter
PriceLoading...
Change-$0.00 (-0.00%)
Volume$9.5K
Capitalization5.4B
Cannara Biotech
Price$1.17
Change-$0.10 (-7.87%)
Volume$11.86K
Capitalization111.76M
GEDSF vs LOVFF Comparison Chart in %
LOVFF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GEDSF vs. LOVFF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEDSF is a Hold and LOVFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GEDSF: $22.29 vs. LOVFF: $1.17)
Brand notoriety: GEDSF and LOVFF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GEDSF: 100% vs. LOVFF: 337%
Market capitalization -- GEDSF: $5.4B vs. LOVFF: $111.76M
GEDSF [@Pharmaceuticals: Generic] is valued at $5.4B. LOVFF’s [@Pharmaceuticals: Generic] market capitalization is $111.76M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEDSF’s FA Score shows that 1 FA rating(s) are green whileLOVFF’s FA Score has 0 green FA rating(s).

  • GEDSF’s FA Score: 1 green, 4 red.
  • LOVFF’s FA Score: 0 green, 5 red.
According to our system of comparison, LOVFF is a better buy in the long-term than GEDSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LOVFF’s TA Score shows that 3 TA indicator(s) are bullish.

  • LOVFF’s TA Score: 3 bullish, 6 bearish.

Price Growth

GEDSF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LOVFF (@Pharmaceuticals: Generic) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.58%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +30.64%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.58% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEDSF($5.4B) has a higher market cap than LOVFF($112M). GEDSF has higher P/E ratio than LOVFF: GEDSF (10.64) vs LOVFF (9.65). LOVFF YTD gains are higher at: 146.764 vs. GEDSF (-4.699). GEDSF has higher annual earnings (EBITDA): 335B vs. LOVFF (27M). GEDSF has more cash in the bank: 150B vs. LOVFF (14.4M). LOVFF has less debt than GEDSF: LOVFF (47.5M) vs GEDSF (21.6B). GEDSF has higher revenues than LOVFF: GEDSF (903B) vs LOVFF (102M).
GEDSFLOVFFGEDSF / LOVFF
Capitalization5.4B112M4,824%
EBITDA335B27M1,240,741%
Gain YTD-4.699146.764-3%
P/E Ratio10.649.65110%
Revenue903B102M885,294%
Total Cash150B14.4M1,041,667%
Total Debt21.6B47.5M45,474%
FUNDAMENTALS RATINGS
GEDSF vs LOVFF: Fundamental Ratings
GEDSF
LOVFF
OUTLOOK RATING
1..100
502
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
6565
SMR RATING
1..100
4850
PRICE GROWTH RATING
1..100
7141
P/E GROWTH RATING
1..100
8136
SEASONALITY SCORE
1..100
3050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GEDSF's Valuation (2) in the null industry is somewhat better than the same rating for LOVFF (56). This means that GEDSF’s stock grew somewhat faster than LOVFF’s over the last 12 months.

GEDSF's Profit vs Risk Rating (65) in the null industry is in the same range as LOVFF (65). This means that GEDSF’s stock grew similarly to LOVFF’s over the last 12 months.

GEDSF's SMR Rating (48) in the null industry is in the same range as LOVFF (50). This means that GEDSF’s stock grew similarly to LOVFF’s over the last 12 months.

LOVFF's Price Growth Rating (41) in the null industry is in the same range as GEDSF (71). This means that LOVFF’s stock grew similarly to GEDSF’s over the last 12 months.

LOVFF's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for GEDSF (81). This means that LOVFF’s stock grew somewhat faster than GEDSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GEDSFLOVFF
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
72%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
LOVFF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JOPSX14.690.13
+0.89%
JOHCM International Opps Institutional
ANWPX75.290.24
+0.32%
American Funds New Perspective A
VYMVX19.150.02
+0.10%
Voya MI Dynamic SMID Cap R
CFIMX15.530.01
+0.06%
Clipper
FIKNX20.30N/A
N/A
Fidelity Advisor Small Cap Value Z

GEDSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEDSF has been loosely correlated with APNHF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GEDSF jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEDSF
1D Price
Change %
GEDSF100%
N/A
APNHF - GEDSF
51%
Loosely correlated
N/A
UPC - GEDSF
4%
Poorly correlated
+2.22%
KKPCF - GEDSF
3%
Poorly correlated
N/A
CLCFF - GEDSF
3%
Poorly correlated
+33.71%
OPTHF - GEDSF
0%
Poorly correlated
N/A
More

LOVFF and

Correlation & Price change

A.I.dvisor tells us that LOVFF and KKPCF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LOVFF and KKPCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LOVFF
1D Price
Change %
LOVFF100%
+7.37%
KKPCF - LOVFF
6%
Poorly correlated
N/A
VTRS - LOVFF
3%
Poorly correlated
-1.70%
VEXTF - LOVFF
1%
Poorly correlated
+2.63%
GEDSF - LOVFF
-0%
Poorly correlated
N/A
IMCC - LOVFF
-0%
Poorly correlated
-2.04%
More